Pittsburgh spin-out ALung Technologies partners National University Hospital Singapore on acute respiratory distress syndrome study.

Novartis and Cleveland Clinic returned to fund the medical device maker's series D round, which increased its overall funding to $95m.

The consumer healthcare company has raised a series A round from investors including Qualcomm Ventures to expand across Europe.

Genome editing technology developer Precision BioSciences has raised $25.6m in funding from backers including Amgen and Baxter's corporate venturing units.

Novozymes and Sobrato Organisation were among the backers for life sciences-based venture firm Mission Bay Capital's oversubscribed second fund.

Novo Seeds, Lundbeck, Merck and Astellas all exited EpiTherapeutics after it was acquired by biopharmaceutical firm Gilead.

Celgene provided $30m as part of the deal and secured the right to eventually acquire the biotechnology company, which focuses on cancer and fibrosis.